Was macht Ocugen INC?
Ocugen, Inc. ist ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung von Gentherapien zur Heilung von Erblindungskrankheiten und die Entwicklung eines Impfstoffs für COVID-19 konzentriert.
Wo wird Ocugen gehandelt?
Die Ocugen Inc Registered Shs Aktie wird unter der ISIN US67577C1053 an den Börsen Frankfurt, Düsseldorf, München, Stuttgart, Hamburg, Berlin, NASDAQ, Mexiko, Bats, NDB, Gettex, Tradegate, Lang & Schwarz, Baader Bank und Quotrix gehandelt. Ocugen Inc Registered Shs ist ein Unternehmen aus den USA.
Welche Aktien jetzt kaufen 2021?
Watchlist Aktien: Das waren die 20 begehrtesten Aktien im November 2021
- Amazon (ISIN: US0231351067)
- Apple (ISIN: US0378331005)
- Tesla (ISIN: US88160R1014)
- Allianz (ISIN: DE0008404005)
- Biontech (ISIN: US09075V1026)
- Bayer (ISIN: DE000BAY0017)
- Microsoft (ISIN: US5949181045)
- Gamestop (ISIN: US36467W1099)
What does openocugen (ocgn) plan to do with $100 million?
Ocugen (OCGN), a gene therapy company that aims to cure blindness, is set to close the direct offering on April 27 and it expects gross proceeds of $100 million from this offering. The company intends to use the net proceeds for working capital needs, general corporate purposes and capex.
How many shareholders does ocugen Inc have?
Institutional Ownership and Shareholders Ocugen Inc (US:OCGN) has 108 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30,337,843 shares.
Is $ocgn getting ready to pop?
Taking a look at the carts, it looks like $OCGN has had quite a bid of consolidation and is tracking the last wedge (purple lines) fairly well. Thinking this may see a short run up. OCGN is looking like its getting ready on the hourly to pop.